Jennifer Phillips

Director of Research/Assistant Professor

University of Ottawa

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jennifer Phillips is the Director of Research and an Assistant Professor at the University of Ottawa, Canada. Her research focuses on major depressive disorder and its treatment, particularly investigating the effects of ketamine infusions and behavioral therapies. Recent articles authored by Dr. Phillips explore topics such as sensory gating alterations, cognitive function in treatment-resistant depression, and the relationship between mental health and moral distress in healthcare workers during the COVID-19 pandemic.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

John Deakin

The University of Manchester

UNITED KINGDOM

View details

Rebecca B. Price

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jennifer Phillips

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder

Auditory P50 Sensory Gating Alterations in Major Depressive Disorder and their Relationship to Clinical Symptoms.

Sustaining the benefits of intravenous ketamine with behavioural activation therapy for depression: A case series

Free-Water Diffusion Magnetic Resonance Imaging Differentiates Suicidal Ideation From Suicide Attempt in Treatment-Resistant Depression

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators.

A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Non-Suicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine.

Assessment of objective and subjective cognitive function in patients with treatment-resistant depression undergoing repeated ketamine infusions.

Sex Differences in Determinants of Suicide Risk Preceding Psychiatric Admission: An Electronic Medical Record Study

The new frontline: exploring the links between moral distress, moral resilience and mental health in healthcare workers during the COVID-19 pandemic.

Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

Collaborators (2)

John Deakin

Rebecca B. Price

Make your next move.